Advanced company searchLink opens in new window

GENEDRIVE DIAGNOSTICS LTD

Company number 03901952

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
12 Aug 2024 TM01 Termination of appointment of James Bernard Cheek as a director on 6 August 2024
18 Jan 2024 CS01 Confirmation statement made on 18 January 2024 with no updates
02 Jan 2024 AA Full accounts made up to 30 June 2023
13 Sep 2023 TM01 Termination of appointment of David Budd as a director on 11 September 2023
13 Sep 2023 AP01 Appointment of Dr Gino Miele as a director on 11 September 2023
13 Sep 2023 AP01 Appointment of Mr James Bernard Cheek as a director on 11 September 2023
23 Mar 2023 AA Full accounts made up to 30 June 2022
20 Jan 2023 CS01 Confirmation statement made on 18 January 2023 with no updates
08 Apr 2022 CH01 Director's details changed for Mr Russ Shaw on 29 March 2022
29 Mar 2022 TM01 Termination of appointment of Matthew John Fowler as a director on 29 March 2022
29 Mar 2022 TM02 Termination of appointment of Matthew John Fowler as a secretary on 29 March 2022
29 Mar 2022 AP01 Appointment of Mr Russ Shaw as a director on 29 March 2022
18 Jan 2022 CS01 Confirmation statement made on 18 January 2022 with no updates
19 Nov 2021 AA Full accounts made up to 30 June 2021
25 Mar 2021 CS01 Confirmation statement made on 26 January 2021 with no updates
15 Dec 2020 AA Full accounts made up to 30 June 2020
27 Jan 2020 CS01 Confirmation statement made on 26 January 2020 with updates
09 Dec 2019 AUD Auditor's resignation
21 Oct 2019 AA Full accounts made up to 30 June 2019
12 Jun 2019 SH19 Statement of capital on 12 June 2019
  • GBP 2.57
05 Jun 2019 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES13 ‐ Share cap inc 16/05/2019
31 May 2019 SH20 Statement by Directors
31 May 2019 CAP-SS Solvency Statement dated 20/05/19
31 May 2019 RESOLUTIONS Resolutions
  • RES13 ‐ Reduce share prem a/c 20/05/2019
  • RES06 ‐ Resolution of reduction in issued share capital
21 Mar 2019 SH20 Statement by Directors